Eli Lilly stood up the Global Business Solutions organization in 2011 with an initial focus on finance capabilities for the wider enterprise. Twelve years on, it has evolved and grown its finance capabilities while also diversifying into new business areas including clinical, medical and commercial, supporting more than 40 countries globally. In 2020, after a decade partnering with an outsourced BPO, the GBS P2P team took a strategic decision to insource, with a view to drive further automated solutions and continuous improvement initiatives. To effectively support the full scope of the insourced P2P activities, it was necessary for Lilly to invest in new technologies to enable all aspects of the insourced scope.
Diane Coey, Global Purchase Owner, Purchase to Pay, will share:
The tangible benefits from investing in a pro-active approach to supplier statement reconciliation which has resulted in the immediate identification and recoupment of more than:
Book a live demo to see the end-to-end processes on live customers systems and learn how easy it is to try this for free on a Proof of Concept.
Book a Live Demo to see the end-to-end processes on live customers systems and learn how easy it is to try this for free on a Proof of Concept.